J.P. Morgan Life Sciences Private Capital

J.P. Morgan Growth Equity Partners is JPMorgan Chase’s growth-equity and venture investment platform focused on U.S. technology companies approaching scale and IPO readiness. It invests through 270 Growth Fund I and related vehicles across early-stage VC, later-stage VC and growth-equity rounds, and has acted as a co-lead investor. The platform targets software, real estate technology, financial technology and consumer technology companies, with observed exposure to AI, analytics, logistics, SaaS and supply chain businesses.